ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, announced the appointment of John Sory to the newly created role of Senior Vice President of Health Care Solutions.This strategic appointment will enable ERT to leverage its core expertise into the larger health care market. Mr. Sory will be responsible for developing this growth area as well as exploring merger and acquisition opportunities in clinical research. He will report to the President and CEO of ERT, Dr Michael McKelvey. 

The health care industry increasingly requires technical connectivity across the health system, remote clinical review and data services to augment and support the process of care delivery and robust analytics to evaluate the improvement in patient health. ERT is highly experienced in developing similar comprehensive, efficient, centralized solutions for the clinical trials industry. This new appointment demonstrates the Company’s desire to leverage and expand its established expertise and core capabilities, with the ultimate goal of building diversified revenue streams to complement our clinical trial business.

Mr. Sory joins ERT following 16 years of experience working for Pfizer, Inc. He spent the last seven years as Vice President and General Manager of Pfizer Health Solutions, Inc, Pfizer’s health technology and services subsidiary. John brings extensive business development experience working on partnerships, joint ventures, and mergers, as well as operations experience having managed innovative health care initiatives in the U.S. and Europe. A high level industry executive, Mr. Sory has demonstrated his ability to successfully leverage a company’s resources, talent and intellectual property across many divergent sectors of the health care system.

Dr Michael McKelvey, President and CEO of ERT, comments, “with his wealth of new business development and managerial experience and capabilities, we are confident that John will establish ERT’s presence in the broader health care market. His appointment marks the next stage of ERT’s continued investment to growing our business into adjacent and complementary markets.”